Comprehensive proteome analysis of malignant pleural effusion for lung cancer biomarker discovery by using multidimensional protein identification technology

Journal of Proteome Research

Volumn 10, Issue 10, 2011, Pages 4671-4682

  Yu, Chia Jung ^a   Wang, Chih Liang ^a,b   Wang, Chun I ^a   Chen, Chi De ^a   Dan, Yu Min ^a   Wu, Chih Ching ^a   Wu, Yi Cheng ^c   Lee, I Neng ^a   Tsai, Ying Huang ^b   Chang, Yu Sun ^a   Yu, Jau Song ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b Department of Thoracic Medicine   (United States)

^c CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

biomarker; IGFBP2; lung cancer; malignant pleural effusion; proteome

Indexed keywords

ANGIOGENIN; BIOLOGICAL MARKER; CYSTATIN C; FETUIN A; SOMATOMEDIN BINDING PROTEIN 2;

ADULT; AGED; ARTICLE; BACTERIAL PNEUMONIA; CANCER CELL CULTURE; CANCER DIAGNOSIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LIQUID CHROMATOGRAPHY; LUNG ADENOCARCINOMA; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PLEURA EFFUSION; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEOMICS; TANDEM MASS SPECTROMETRY; TUBERCULOSIS;

AGED; AGED, 80 AND OVER; ALPHA-2-HS-GLYCOPROTEIN; COMPUTATIONAL BIOLOGY; DATABASES, FACTUAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 2; LUNG NEOPLASMS; MALE; MIDDLE AGED; PLEURAL EFFUSION, MALIGNANT; PROTEOMICS; TUMOR MARKERS, BIOLOGICAL;

EID: 80053927128     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr2004743     Document Type: Article

References (87)

1. Ferlay, J.; Shin, H. R.; Bray, F.; Forman, D.; Mathers, C.; Parkin, D. M. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 Int. J. Cancer 2010, 127 (12) 2893-917
2. Molina, J. R.; Yang, P.; Cassivi, S. D.; Schild, S. E.; Adjei, A. A. Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship Mayo Clin. Proc. 2008, 83 (5) 584-94 (Pubitemid 351720831)
3. Charloux, A.; Quoix, E.; Wolkove, N.; Small, D.; Pauli, G.; Kreisman, H. The increasing incidence of lung adenocarcinoma: reality or artefact? A review of the epidemiology of lung adenocarcinoma Int. J. Epidemiol. 1997, 26 (1) 14-23 (Pubitemid 27129564)
4. Jemal, A.; Siegel, R.; Ward, E.; Hao, Y.; Xu, J.; Murray, T.; Thun, M. J. Cancer statistics, 2008 CA Cancer J. Clin. 2008, 58 (2) 71-96 (Pubitemid 351521864)
5. Mulshine, J. L.; Sullivan, D. C. Clinical practice. Lung cancer screening N. Engl. J. Med. 2005, 352 (26) 2714-20 (Pubitemid 41007826)
6. Andrews, C. O.; Gora, M. L. Pleural effusions: pathophysiology and management Ann. Pharmacother. 1994, 28 (7-8) 894-903 (Pubitemid 24262661)
7. Johnston, W. W. The malignant pleural effusion. A review of cytopathologic diagnoses of 584 specimens from 472 consecutive patients Cancer 1985, 56 (4) 905-9 (Pubitemid 15228290)
8. Memon, A.; Zawadzki, Z. A. Malignant effusions: diagnostic evaluation and therapeutic strategy Curr. Probl. Cancer 1981, 5 (8) 1-30
9. Heffner, J. E.; Klein, J. S. Recent advances in the diagnosis and management of malignant pleural effusions Mayo Clin. Proc. 2008, 83 (2) 235-50 (Pubitemid 351303104)
10. Sahn, S. A. Pleural diseases related to metastatic malignancies Eur. Respir. J. 1997, 10 (8) 1907-13 (Pubitemid 27368388)
11. Rami-Porta, R.; Ball, D.; Crowley, J.; Giroux, D. J.; Jett, J.; Travis, W. D.; Tsuboi, M.; Vallieres, E.; Goldstraw, P. The IASLC Lung Cancer Staging Project: proposals for the revision of the T descriptors in the forthcoming (seventh) edition of the TNM classification for lung cancer J. Thorac. Oncol. 2007, 2 (7) 593-602 (Pubitemid 47171780)
12. Heffner, J. E.; Nietert, P. J.; Barbieri, C. Pleural fluid pH as a predictor of survival for patients with malignant pleural effusions Chest 2000, 117 (1) 79-86 (Pubitemid 30053624)
13. Ong, K. C.; Indumathi, V.; Poh, W. T.; Ong, Y. Y. The diagnostic yield of pleural fluid cytology in malignant pleural effusions Singapore Med. J. 2000, 41 (1) 19-23
14. Prakash, U. B.; Reiman, H. M. Comparison of needle biopsy with cytologic analysis for the evaluation of pleural effusion: analysis of 414 cases Mayo Clin. Proc. 1985, 60 (3) 158-64 (Pubitemid 15139121)
15. Sallach, S. M.; Sallach, J. A.; Vasquez, E.; Schultz, L.; Kvale, P. Volume of pleural fluid required for diagnosis of pleural malignancy Chest 2002, 122 (6) 1913-7 (Pubitemid 36051124)
16. Motherby, H.; Nadjari, B.; Friegel, P.; Kohaus, J.; Ramp, U.; Bocking, A. Diagnostic accuracy of effusion cytology Diagn. Cytopathol. 1999, 20 (6) 350-7 (Pubitemid 29239366)
17. Shijubo, N.; Honda, Y.; Fujishima, T.; Takahashi, H.; Kodama, T.; Kuroki, Y.; Akino, T.; Abe, S. Lung surfactant protein-A and carcinoembryonic antigen in pleural effusions due to lung adenocarcinoma and malignant mesothelioma Eur. Respir. J. 1995, 8 (3) 403-6
18. Domej, W.; Tilz, G. P.; Foldes-Papp, Z.; Demel, U.; Rabold, T.; Holzer, H. Cystatin C of pleural effusion as a novel diagnostic aid in pleural diseases of different aetiologies Clin. Sci. (London) 2002, 102 (3) 373-80 (Pubitemid 34214401)
19. Cheng, D.; Rodriguez, R. M.; Perkett, E. A.; Rogers, J.; Bienvenu, G.; Lappalainen, U.; Light, R. W. Vascular endothelial growth factor in pleural fluid Chest 1999, 116 (3) 760-5 (Pubitemid 29428497)
20. Bard, M. P.; Hegmans, J. P.; Hemmes, A.; Luider, T. M.; Willemsen, R.; Severijnen, L. A.; van Meerbeeck, J. P.; Burgers, S. A.; Hoogsteden, H. C.; Lambrecht, B. N. Proteomic analysis of exosomes isolated from human malignant pleural effusions Am. J. Respir. Cell Mol. Biol. 2004, 31 (1) 114-21 (Pubitemid 38888047)
21. Hsieh, W. Y.; Chen, M. W.; Ho, H. T.; You, T. M.; Lu, Y. T. Identification of differentially expressed proteins in human malignant pleural effusions Eur. Respir. J. 2006, 28 (6) 1178-85
22. Rodriguez-Pineiro, A. M.; Blanco-Prieto, S.; Sanchez-Otero, N.; Rodriguez-Berrocal, F. J.; de la Cadena, M. P. On the identification of biomarkers for non-small cell lung cancer in serum and pleural effusion J. Proteomics 2010, 73 (8) 1511-22
23. Pernemalm, M.; De Petris, L.; Eriksson, H.; Branden, E.; Koyi, H.; Kanter, L.; Lewensohn, R.; Lehtio, J. Use of narrow-range peptide IEF to improve detection of lung adenocarcinoma markers in plasma and pleural effusion Proteomics 2009, 9 (13) 3414-24
24. Anderson, N. L.; Anderson, N. G. The human plasma proteome: history, character, and diagnostic prospects Mol. Cell. Proteomics 2002, 1 (11) 845-67
25. Good, D. M.; Thongboonkerd, V.; Novak, J.; Bascands, J. L.; Schanstra, J. P.; Coon, J. J.; Dominiczak, A.; Mischak, H. Body fluid proteomics for biomarker discovery: lessons from the past hold the key to success in the future J. Proteome Res. 2007, 6 (12) 4549-55
26. Olsen, J. V.; de Godoy, L. M.; Li, G.; Macek, B.; Mortensen, P.; Pesch, R.; Makarov, A.; Lange, O.; Horning, S.; Mann, M. Parts per million mass accuracy on an Orbitrap mass spectrometer via lock mass injection into a C-trap Mol. Cell. Proteomics 2005, 4 (12) 2010-21 (Pubitemid 41830195)
27. Yu, C. J.; Chen, Y. C.; Hsiao, C. H.; Kuo, T. C.; Chang, S. C.; Lu, C. Y.; Wei, W. C.; Lee, C. H.; Huang, L. M.; Chang, M. F.; Ho, H. N.; Lee, F. J. Identification of a novel protein 3a from severe acute respiratory syndrome coronavirus FEBS Lett. 2004, 565 (1-3) 111-6 (Pubitemid 38595329)
28. Hanley, J. A.; McNeil, B. J. A method of comparing the areas under receiver operating characteristic curves derived from the same cases Radiology 1983, 148 (3) 839-43 (Pubitemid 13033817)
29. Youden, W. J. Index for rating diagnostic tests Cancer 1950, 3 (1) 32-5
30. Davidson, B. Malignant effusions: from diagnosis to biology Diagn. Cytopathol. 2004, 31 (4) 246-54 (Pubitemid 39314820)
31. Tyan, Y. C.; Wu, H. Y.; Lai, W. W.; Su, W. C.; Liao, P. C. Proteomic profiling of human pleural effusion using two-dimensional nano liquid chromatography tandem mass spectrometry J. Proteome Res. 2005, 4 (4) 1274-86
32. Andre, F.; Schartz, N. E.; Movassagh, M.; Flament, C.; Pautier, P.; Morice, P.; Pomel, C.; Lhomme, C.; Escudier, B.; Le Chevalier, T.; Tursz, T.; Amigorena, S.; Raposo, G.; Angevin, E.; Zitvogel, L. Malignant effusions and immunogenic tumour-derived exosomes Lancet 2002, 360 (9329) 295-305 (Pubitemid 34874721)
33. Planque, C.; Kulasingam, V.; Smith, C. R.; Reckamp, K.; Goodglick, L.; Diamandis, E. P. Identification of five candidate lung cancer biomarkers by proteomics analysis of conditioned media of four lung cancer cell lines Mol. Cell. Proteomics 2009, 8 (12) 2746-58
34. Wang, C. L.; Wang, C. I.; Liao, P. C.; Chen, C. D.; Liang, Y.; Chuang, W. Y.; Tsai, Y. H.; Chen, H. C.; Chang, Y. S.; Yu, J. S.; Wu, C. C.; Yu, C. J. Discovery of retinoblastoma-associated binding protein 46 as a novel prognostic marker for distant metastasis in nonsmall cell lung cancer by combined analysis of cancer cell secretome and pleural effusion proteome J. Proteome Res. 2009, 8 (10) 4428-40
35. Bendtsen, J. D.; Nielsen, H.; von Heijne, G.; Brunak, S. Improved prediction of signal peptides: SignalP 3.0 J. Mol. Biol. 2004, 340 (4) 783-95 (Pubitemid 38829638)
36. Nielsen, H.; Krogh, A. Prediction of signal peptides and signal anchors by a hidden Markov model Proc. Int. Conf. Intell. Syst. Mol. Biol. 1998, 6, 122-30
37. Bendtsen, J. D.; Jensen, L. J.; Blom, N.; Von Heijne, G.; Brunak, S. Feature-based prediction of non-classical and leaderless protein secretion Protein Eng. Des. Sel. 2004, 17 (4) 349-56 (Pubitemid 39093515)
38. Moller, S.; Croning, M. D.; Apweiler, R. Evaluation of methods for the prediction of membrane spanning regions Bioinformatics 2001, 17 (7) 646-53 (Pubitemid 32707587)
39. Ashida, H.; Yamamoto, K.; Kumagai, H. Trypsin inhibitory activity of bovine fetuin de-O-glycosylated by endo-alpha-N-acetylgalactosaminidase Biosci. Biotechnol. Biochem. 2000, 64 (10) 2266-8
40. Galembeck, F.; Cann, J. R. Fetuin as a trypsin inhibitor Arch. Biochem. Biophys. 1974, 164 (1) 326-31
41. Mathews, S. T.; Chellam, N.; Srinivas, P. R.; Cintron, V. J.; Leon, M. A.; Goustin, A. S.; Grunberger, G. Alpha2-HSG, a specific inhibitor of insulin receptor autophosphorylation, interacts with the insulin receptor Mol. Cell. Endocrinol. 2000, 164 (1-2) 87-98 (Pubitemid 30665503)
42. Srinivas, P. R.; Wagner, A. S.; Reddy, L. V.; Deutsch, D. D.; Leon, M. A.; Goustin, A. S.; Grunberger, G. Serum alpha 2-HS-glycoprotein is an inhibitor of the human insulin receptor at the tyrosine kinase level Mol. Endocrinol. 1993, 7 (11) 1445-55
43. Hedrich, J.; Lottaz, D.; Meyer, K.; Yiallouros, I.; Jahnen-Dechent, W.; Stocker, W.; Becker-Pauly, C. Fetuin-A and cystatin C are endogenous inhibitors of human meprin metalloproteases Biochemistry 2010, 49 (39) 8599-607
44. Barcellos-Hoff, M. H.; Ewan, K. B. Transforming growth factor-beta and breast cancer: Mammary gland development Breast Cancer Res. 2000, 2 (2) 92-9 (Pubitemid 32223571)
45. Schafer, C.; Heiss, A.; Schwarz, A.; Westenfeld, R.; Ketteler, M.; Floege, J.; Muller-Esterl, W.; Schinke, T.; Jahnen-Dechent, W. The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification J. Clin. Invest. 2003, 112 (3) 357-66 (Pubitemid 38063764)
46. Schinke, T.; Amendt, C.; Trindl, A.; Poschke, O.; Muller-Esterl, W.; Jahnen-Dechent, W. The serum protein alpha2-HS glycoprotein/fetuin inhibits apatite formation in vitro and in mineralizing calvaria cells. A possible role in mineralization and calcium homeostasis J. Biol. Chem. 1996, 271 (34) 20789-96 (Pubitemid 26281865)
47. Triffitt, J. T.; Owen, M. E.; Ashton, B. A.; Wilson, J. M. Plasma disappearance of rabbit alpha2HS-glycoprotein and its uptake by bone tissue Calcif. Tissue Res. 1978, 26 (2) 155-61
48. Kundranda, M. N.; Henderson, M.; Carter, K. J.; Gorden, L.; Binhazim, A.; Ray, S.; Baptiste, T.; Shokrani, M.; Leite-Browning, M. L.; Jahnen-Dechent, W.; Matrisian, L. M.; Ochieng, J. The serum glycoprotein fetuin-A promotes Lewis lung carcinoma tumorigenesis via adhesive-dependent and adhesive-independent mechanisms Cancer Res. 2005, 65 (2) 499-506
49. Swallow, C. J.; Partridge, E. A.; Macmillan, J. C.; Tajirian, T.; DiGuglielmo, G. M.; Hay, K.; Szweras, M.; Jahnen-Dechent, W.; Wrana, J. L.; Redston, M.; Gallinger, S.; Dennis, J. W. alpha2HS-glycoprotein, an antagonist of transforming growth factor beta in vivo, inhibits intestinal tumor progression Cancer Res. 2004, 64 (18) 6402-9 (Pubitemid 39297893)
50. Wang, H.; Zhang, M.; Bianchi, M.; Sherry, B.; Sama, A.; Tracey, K. J. Fetuin (alpha2-HS-glycoprotein) opsonizes cationic macrophagedeactivating molecules Proc. Natl. Acad. Sci. U.S.A. 1998, 95 (24) 14429-34
51. Saxena, S. K.; Rybak, S. M.; Davey, R. T., Jr.; Youle, R. J.; Ackerman, E. J. Angiogenin is a cytotoxic, tRNA-specific ribonuclease in the RNase A superfamily J. Biol. Chem. 1992, 267 (30) 21982-6
52. Dickson, K. A.; Kang, D. K.; Kwon, Y. S.; Kim, J. C.; Leland, P. A.; Kim, B. M.; Chang, S. I.; Raines, R. T. Ribonuclease inhibitor regulates neovascularization by human angiogenin Biochemistry 2009, 48 (18) 3804-6
53. Gao, X.; Xu, Z. Mechanisms of action of angiogenin Acta Biochim. Biophys. Sin. (Shanghai) 2008, 40 (7) 619-24 (Pubitemid 352009084)
54. Pavlov, N.; Badet, J. [Angiogenin: involvement in angiogenesis and tumour growth] Bull. Cancer 2001, 88 (8) 725-32 (Pubitemid 32896841)
55. Olson, K. A.; Fett, J. W.; French, T. C.; Key, M. E.; Vallee, B. L. Angiogenin antagonists prevent tumor growth in vivo Proc. Natl. Acad. Sci. U.S.A. 1995, 92 (2) 442-6
56. Yuan, Y.; Wang, F.; Liu, X. H.; Gong, D. J.; Cheng, H. Z.; Huang, S. D. Angiogenin is involved in lung adenocarcinoma cell proliferation and angiogenesis Lung Cancer 2009, 66 (1) 28-36
57. Barrett, A. J.; Davies, M. E.; Grubb, A. The place of human gamma-trace (cystatin C) amongst the cysteine proteinase inhibitors Biochem. Biophys. Res. Commun. 1984, 120 (2) 631-6 (Pubitemid 14101757)
58. Henskens, Y. M.; Veerman, E. C.; Nieuw Amerongen, A. V. Cystatins in health and disease Biol. Chem. Hoppe Seyler 1996, 377 (2) 71-86 (Pubitemid 26089038)
59. Lah, T. T.; Kos, J. Cysteine proteinases in cancer progression and their clinical relevance for prognosis Biol. Chem. 1998, 379 (2) 125-30 (Pubitemid 28075971)
60. Cox, J. L. Cystatins and cancer Front. Biosci. 2009, 14, 463-74
61. Ebert, E.; Werle, B.; Julke, B.; Kopitar-Jerala, N.; Kos, J.; Lah, T.; Abrahamson, M.; Spiess, E.; Ebert, W. Expression of cysteine protease inhibitors stefin A, stefin B, and cystatin C in human lung tumor tissue Adv. Exp. Med. Biol. 1997, 421, 259-65 (Pubitemid 27432679)
62. Konduri, S. D.; Yanamandra, N.; Siddique, K.; Joseph, A.; Dinh, D. H.; Olivero, W. C.; Gujrati, M.; Kouraklis, G.; Swaroop, A.; Kyritsis, A. P.; Rao, J. S. Modulation of cystatin C expression impairs the invasive and tumorigenic potential of human glioblastoma cells Oncogene 2002, 21 (57) 8705-12 (Pubitemid 36132391)
63. Kos, J.; Krasovec, M.; Cimerman, N.; Nielsen, H. J.; Christensen, I. J.; Brunner, N. Cysteine proteinase inhibitors stefin A, stefin B, and cystatin C in sera from patients with colorectal cancer: relation to prognosis Clin. Cancer Res. 2000, 6 (2) 505-11 (Pubitemid 30111471)
64. Strojan, P.; Oblak, I.; Svetic, B.; Smid, L.; Kos, J. Cysteine proteinase inhibitor cystatin C in squamous cell carcinoma of the head and neck: relation to prognosis Br. J. Cancer 2004, 90 (10) 1961-8 (Pubitemid 38746337)
65. Wegiel, B.; Jiborn, T.; Abrahamson, M.; Helczynski, L.; Otterbein, L.; Persson, J. L.; Bjartell, A. Cystatin C is downregulated in prostate cancer and modulates invasion of prostate cancer cells via MAPK/Erk and androgen receptor pathways PLoS One 2009, 4 (11) e7953
66. Werle, B.; Schanzenbacher, U.; Lah, T. T.; Ebert, E.; Julke, B.; Ebert, W.; Fiehn, W.; Kayser, K.; Spiess, E.; Abrahamson, M.; Kos, J. Cystatins in non-small cell lung cancer: tissue levels, localization and relation to prognosis Oncol. Rep. 2006, 16 (4) 647-55
67. Yano, M.; Hirai, K.; Naito, Z.; Yokoyama, M.; Ishiwata, T.; Shiraki, Y.; Inokuchi, M.; Asano, G. Expression of cathepsin B and cystatin C in human breast cancer Surg. Today 2001, 31 (5) 385-9 (Pubitemid 32441901)
68. Nishikawa, H.; Ozaki, Y.; Nakanishi, T.; Blomgren, K.; Tada, T.; Arakawa, A.; Suzumori, K. The role of cathepsin B and cystatin C in the mechanisms of invasion by ovarian cancer Gynecol. Oncol. 2004, 92 (3) 881-6 (Pubitemid 38251392)
69. Hwa, V.; Oh, Y.; Rosenfeld, R. G. The insulin-like growth factor-binding protein (IGFBP) superfamily Endocr. Rev. 1999, 20 (6) 761-87 (Pubitemid 30648894)
70. Hoeflich, A.; Reisinger, R.; Lahm, H.; Kiess, W.; Blum, W. F.; Kolb, H. J.; Weber, M. M.; Wolf, E. Insulin-like growth factor-binding protein 2 in tumorigenesis: protector or promoter? Cancer Res. 2001, 61 (24) 8601-10 (Pubitemid 34013863)
71. Kiyama, S.; Morrison, K.; Zellweger, T.; Akbari, M.; Cox, M.; Yu, D.; Miyake, H.; Gleave, M. E. Castration-induced increases in insulin-like growth factor-binding protein 2 promotes proliferation of androgen-independent human prostate LNCaP tumors Cancer Res. 2003, 63 (13) 3575-84 (Pubitemid 36793038)
72. Olchovsky, D.; Shimon, I.; Goldberg, I.; Shulimzon, T.; Lubetsky, A.; Yellin, A.; Pariente, C.; Karasik, A.; Kanety, H. Elevated insulin-like growth factor-1 and insulin-like growth factor binding protein-2 in malignant pleural effusion Acta Oncol. 2002, 41 (2) 182-7 (Pubitemid 34557080)
73. Wang, H.; Rosen, D. G.; Fuller, G. N.; Zhang, W.; Liu, J. Insulin-like growth factor-binding protein 2 and 5 are differentially regulated in ovarian cancer of different histologic types Mod. Pathol. 2006, 19 (9) 1149-56 (Pubitemid 44268184)
74. Wang, H.; Arun, B. K.; Fuller, G. N.; Zhang, W.; Middleton, L. P.; Sahin, A. A. IGFBP2 and IGFBP5 overexpression correlates with the lymph node metastasis in T1 breast carcinomas Breast J. 2008, 14 (3) 261-7 (Pubitemid 351678058)
75. Zhang, L.; Huang, W.; Chen, J.; Zhou, X.; Lu, Z.; Zhou, H. Expression of IGFBP2 in gastric carcinoma and relationship with clinicopathologic parameters and cell proliferation Dig. Dis. Sci. 2007, 52 (1) 248-53 (Pubitemid 46122075)
76. Becher, O. J.; Peterson, K. M.; Khatua, S.; Santi, M. R.; MacDonald, T. J. IGFBP2 is overexpressed by pediatric malignant astrocytomas and induces the repair enzyme DNA-PK J. Child Neurol. 2008, 23 (10) 1205-13
77. Wang, H.; Shen, W.; Huang, H.; Hu, L.; Ramdas, L.; Zhou, Y. H.; Liao, W. S.; Fuller, G. N.; Zhang, W. Insulin-like growth factor binding protein 2 enhances glioblastoma invasion by activating invasion-enhancing genes Cancer Res. 2003, 63 (15) 4315-21 (Pubitemid 36950996)
78. Zhang, W.; Fuller, G. IGFBP2 as a brain tumor oncogene Cancer Biol. Ther. 2007, 6 (7) 995-6
79. Pereira, J. J.; Meyer, T.; Docherty, S. E.; Reid, H. H.; Marshall, J.; Thompson, E. W.; Rossjohn, J.; Price, J. T. Bimolecular interaction of insulin-like growth factor (IGF) binding protein-2 with alphavbeta3 negatively modulates IGF-I-mediated migration and tumor growth Cancer Res. 2004, 64 (3) 977-84 (Pubitemid 38176900)
80. Guadagni, F.; Roselli, M.; Cosimelli, M.; Spila, A.; Cavaliere, F.; Arcuri, R.; D'Alessandro, R.; Fracasso, P. L.; Casale, V.; Vecchione, A.; Casciani, C. U.; Greiner, J. W.; Schlom, J. Quantitative analysis of CEA expression in colorectal adenocarcinoma and serum: lack of correlation Int. J. Cancer 1997, 72 (6) 949-54 (Pubitemid 27433556)
81. Ogawa, M.; Yanoma, S.; Nagashima, Y.; Okamoto, N.; Ishikawa, H.; Haruki, A.; Miyagi, E.; Takahashi, T.; Hirahara, F.; Miyagi, Y. Paradoxical discrepancy between the serum level and the placental intensity of PP5/TFPI-2 in preeclampsia and/or intrauterine growth restriction: possible interaction and correlation with glypican-3 hold the key Placenta 2007, 28 (2-3) 224-32 (Pubitemid 44914519)
82. Oue, N.; Kuniyasu, H.; Noguchi, T.; Sentani, K.; Ito, M.; Tanaka, S.; Setoyama, T.; Sakakura, C.; Natsugoe, S.; Yasui, W. Serum concentration of Reg IV in patients with colorectal cancer: overexpression and high serum levels of Reg IV are associated with liver metastasis Oncology 2007, 72 (5-6) 371-80 (Pubitemid 351238152)
83. Weir, E. G.; Partin, A. W.; Epstein, J. I. Correlation of serum prostate specific antigen and quantitative immunohistochemistry J. Urol. 2000, 163 (6) 1739-42 (Pubitemid 30366725)
84. Werle, B.; Sauckel, K.; Nathanson, C. M.; Bjarnadottir, M.; Spiess, E.; Ebert, W.; Abrahamson, M. Cystatins C, E/M and F in human pleural fluids of patients with neoplastic and inflammatory lung disorders Biol. Chem. 2003, 384 (2) 281-7 (Pubitemid 36348328)
85. Liang, Q. L.; Shi, H. Z.; Qin, X. J.; Liang, X. D.; Jiang, J.; Yang, H. B. Diagnostic accuracy of tumour markers for malignant pleural effusion: a meta-analysis Thorax 2008, 63 (1) 35-41
86. Huang, W. W.; Tsao, S. M.; Lai, C. L.; Su, C. C.; Tseng, C. E. Diagnostic value of Her-2/neu, Cyfra 21-1, and carcinoembryonic antigen levels in malignant pleural effusions of lung adenocarcinoma Pathology 2010, 42 (3) 224-8
87. LeRoith, D.; Roberts, C. T., Jr. The insulin-like growth factor system and cancer Cancer Lett. 2003, 195 (2) 127-37